The muscle pump activator device: From evidence to lived experiences

Area of Science:

• Wound Healing
• Biomedical Engineering
• Vascular Physiology

Background:

• Chronic wounds fail to heal within 3 months, causing significant patient burden and healthcare costs.
• Common chronic wounds include leg ulcers and diabetic foot ulcers, often resistant to standard treatments.
• Existing therapies may be exhausted, creating a need for novel interventions.

Purpose of the Study:

• To review the efficacy of the muscle pump activator (MPA) device in managing chronic wounds.
• To evaluate the MPA device's ability to bridge therapeutic gaps in chronic wound care.
• To present clinical evidence of MPA device effectiveness in improving wound healing and patient outcomes.

Main Methods:

• Review of existing literature on the MPA device and its effects on wound healing.
• Presentation of a series of chronic wound patient cases treated with the MPA device in multicentre clinics.
• Assessment of MPA device's impact on wound outcomes, pain, edema, and quality of life.

Main Results:

• The MPA device stimulates the common peroneal nerve to activate the leg's venous muscle pump, increasing lower leg and foot blood flow.
• Evidence indicates the MPA device improves wound outcomes compared to standard compression therapy, reducing edema and accelerating healing.
• Clinical cases demonstrate MPA device effectiveness in improving wound healing, decreasing pain and edema, and enhancing patient quality of life.

Conclusions:

• The MPA device offers a promising therapeutic option for chronic wounds by enhancing physiological healing mechanisms.
• MPA device application leads to significant improvements in wound healing rates, edema reduction, and patient-reported outcomes.
• The MPA device effectively addresses unmet needs in chronic wound management, improving patient quality of life.